0% found this document useful (0 votes)
142 views

Viii. Drug Study: Drug Action Indications Containdications Side / Adverse Reactions Nursing Consideration

The document summarizes information on several drugs, including their generic and brand names, therapeutic and pharmacologic classes, doctors' orders, dosage instructions, mechanisms of action, indications, contraindications, side effects, and important nursing considerations. Key details are provided for Ranitidine, Cefuroxime, Ceftriaxone, Tramadol, and Paracetamol.

Uploaded by

Sheng Gosep
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
142 views

Viii. Drug Study: Drug Action Indications Containdications Side / Adverse Reactions Nursing Consideration

The document summarizes information on several drugs, including their generic and brand names, therapeutic and pharmacologic classes, doctors' orders, dosage instructions, mechanisms of action, indications, contraindications, side effects, and important nursing considerations. Key details are provided for Ranitidine, Cefuroxime, Ceftriaxone, Tramadol, and Paracetamol.

Uploaded by

Sheng Gosep
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 18

VIII.

DRUG STUDY
DRUG GENERIC NAME: Ranitidine Hydrochloride BRAND NAME: Zantac THERAPEUTIC CLASS: Anti Ulcer dr!" PHARMAC#L#GIC CLASS: H$ rece%tor anta"oni&t& D#CT#R'S #RDER: Ranitidine () *" I+ , -. /hile on NP# DATE STARTED: 0e1r!ary 2$3 $)2) DATE d4c: 0e1r!ary 2-3 $)2) ACTION Co*%etiti5ely inhi1it& action o6 hi&ta*ine on the H$ rece%tor &ite& o6 %arietal cell&3 Decrea&in" "a&tric acid &ecretion7 INDICATIONS Acti5e d!odenal and "a&tric !lcer7 Maintenance thera%y 6or d!odenal or "a&tric !lcer7 Patholo"ic hy%er&ecretory condition& &!ch a& Zollin"er Elli&on Syndro*e7 Ga&troe&o%ha"eal re6l!8 Heart1!rn CONTAINDICATIONS Containdicated in %atient& hy%er&en&iti5e to dr!" and to tho&e /ith ac!te %or%hyria U&e ca!tio!&ly in %atient& /ith he%atic dy&6!nction7 Ad9!&t do&a"e in %atient& /ith i*%aired renal 6!nction7 SIDE / ADVERSE REACTIONS CNS: headache3 *alai&e3 5erti"o EENT: Bl!rred 5i&ion HEPATIC: ana%hyla8i&3 an"ioede*a3 1!rnin" and itchin" at in9ection &ite7 NURSING CONSIDERATION A&&e& %atient 6or a1do*inal :%ain7 Note %re&ence o6 1lood in e*e&i&3 &tool& or "a&tric a&%irate7 Dr!" *ay 1e added to total %arenteral n!trition7 Loo; ali;e < &o!nd ali;e: Don't con6!&e ranitidine /ith ri*antidine= Don't con6!&e >antac /ith 8ana8 or >yrtec7

DRUG GENERIC NAME: Ce6!ro8i*e a8etil BRAND NAME: Ce6tin THERAPEUTIC CLASS: Anti in6ecti5e& PHARMAC#L#GIC CLASS: Second Generation Ce%halo&%orin D#CT#R'S #RDER: Ce6!ro8i*e ?()*" I+ , -. ANST @ A DATE STARTED: 0e1r!ary )B3 $)2) DATE DISC#NTINUE:

ACTION Second "eneration ce%halo&%orin that inhi1it cell /all &ynthe&i&3 %ro*otin" o&*otic in&ta1ility= !&!ally 1actericidal7

INDICATIONS Serio!& re&%iratory tract in6ection&3 UTI3 &;in or &;in &tr!ct!re in6ection&3 1one or 9oint n6ection3 &e%tice*ia3 *enin"iti&3 "onorrhea7 Peri o%erati5e %re5ention Bacterial e8acer1ation o6 chronic 1ronchiti& or &econdary 1acterial in6ection o6 ac!te 1ronchiti& Ac!te 1acterial *a8illary &in!&iti&7 Pharyn"iti& and ton&illiti& #titi& *edia Unco*%licated &;in and &;in &tr!ct!re in6ection& Unco*%licated UTI Unco*%licated "onorrhea Early li*e de&ea&e7

CONTAINDICATIONS Containdicated in %atient& hy%er&en&iti5e to dr!" or other ce%halo&%orin7 U&e ca!tio!&ly in %atient& hy%er&en&iti5e to %enicillin 1eca!&e o6 %o&&i1ility o6 cro&& &en&iti5ity /ith other lacta* anti1iotic& U&e ca!tio!&ly in 1rea&t6eedin" /o*en and in %atient& /ith hi&tory o6 coliti& and renal in&!66iciency7

SIDE / ADVERSE REACTIONS C+: Phle1iti&3 thro*1o%hle1iti&7 GI: Diarrhea3 %&e!do*e*1rano!& coliti&3 na!&ea3 5o*itin"7 HEMAT#L#GIC: he*olytic ane*ia3 thro*1ocyto%enia3 tran&ient ne!tro%enia3 eo&ino%hilia7 SCIN: *ac!lo%o%!lar and erythe*ato!& ra&he&3 !ricaria3 %ain3 ind!ration3 &terile a1&ce&&e&3 te*%erat!re ele5ation3 ti&&!e &lo!"hin" at I7+ 7&ite7 #THER: ana%hyla8i&3 hy%er&en&iti5ity reaction&3 &er!* &ic;ne&&7

NURSING CONSIDERATION Be6ore "i5in" dr!"3 a&; %atient i6 he i& aller"ic to %enicillin or other ca%halo&%horin&3 #1tain &%eci*en 6or c!lt!re and &en&iti5ity te&t& 1e6ore "i5in" 6ir&t do&e7 Thera%y *ay 1e"in /hile a/aitin" re&!lt&7 0or I77M7 !&e3 in9ect dee% into lar"e *!&cle&3 &!ch a& the "l!te!& *a8i*!& or the &ide o6 the thi"h7 A1&or%tion o6 oral dr!" i& enhanced 1y 6ood7 Ta1let& *ay 1e cr!&hed3 i6 a1&ol!tely nece&&ary3 6or %atient& /ho can't &/allo/ can't &/allo/ ta1let&t Ta1let& *ay 1e di&&ol5e in &*all a*o!nt o6 a%%le3 oran"e3 or "ra%e 9!ice or chocolate *il;7Ho/e5er the dr!" *ay 1e 1itter in ta&te that i& di66ic!lt to *a&;3 e5en /ith 6ood7 Alert: Ta1let& and &!&%en&ion aren't 1ioe,!i5alent and can't 1e &!1&tit!ted *illi"ra* 6or *illi"ra*7 Monitor %atient 6or &i"n and &y*%to*& o6

DRUG GENERIC NAME: Tra*adol hydrochloride BRAND NAME: Ultra* THERAPEUTIC CLASS: #%iod anl"e&ic PHARMAC#L#GIC CLASS: Synthetic3 centrally actin" anal"e&ic D#CT#R'S #RDER: Tra*adol 2a*% I+ , -. DATE STARTED: 0e1r!ary )?3 $)2) DATE DISC#NTINUE:

ACTION Un;no/n7 Arally actin" anal"e&ic co*%o!nd not che*ically related to o%iod&7 Tho!"ht to 1ind to o%iod rece%tor& and inhi1it re!%ta;e o6 nore%ine%hrine and &erotonin7

INDICATIONS Moderate to *oderately &e5ere %ain7

CONTAINDICATION S Contraindicated in %atient& hy%er&en&iti5e to dr!" or other o%iod&3 in 1rea&t 6eedin" /o*en3 and in tho&e /ith ac!te into8ication 6ro* alcohol3 hy%notic&3 centrally actin" anal"e&ic&3 o%iod3 %&ychotro%ic dr!"&3 &erio!& hy%er&en&iti5ity reaction& can occ!r3 !&!ally a6ter the 6ir&t do&e7 Patient& /ith hi&tory o6 ana%hylactic reaction to codeine and other o%iod& *ay 1e at increa&e ri&;7

SIDE / ADVERSE REACTIONS CNS: di>>ine&&3 headache7 So*nolence3 5erti"o3 &ei>!re&3 an8iety3 a&thenia3 CNS &ti*!lation3 con6!&ion3 coordination3 di&t!r1ance3 e!%horia3 *alai&e3 ner5o!&ne&&3 *alai&e di&order7 C+: +a&odilation EENT: +i&!al di&t!r1ance&7 GI: con&ti%ation3 na!&ea3 5o*itin"3 a1do*inal %ain3 anore8ia3 diarrhea3 dry *o!th3 dy&%e%&ia3 6lat!lence7 GU: *eno%a!&al &y*%to*&3 %rotein!ria3 !rinary 6re,!ency3 !rine retention7 MUSCUL#SCELET AL: hy%ertonia7 RESPIRAT#RD: re&%iratory de%re&&ion SCIN: dia%hore&i&3 %r!rit!&3 ra&h7

NURSING CONSIDERATION Rea&&e& %atient& le5el o6 %ain atlea&t E) *in a6ter ad*ini&tration7 Monitor C+ and re&%iratory &tat!&7 Fithold clo&e and noti6y %re&cri1er i6 %re&cr1er i6 re&%iration& decrea&e o6 rate i& 1elo/ 2$1%*7 Monitor 1o/el and 1ladder 6!nction7Antici%ate need 6or la8ati5e 0or 1etter anal"e&ic e66ect3 "i5e dr!" 1e6ore on&et o6 o6 inten&e %ain7 Monitor %atient at ri&;& 6or &ei>!re thre&hold7 In the ca&e o6 o5erdo&e3 nalo8one *ay al&o increa&e ri&; o6 &ei>!re7 Monitor %atient 6or dr!" de%endence

&i*ilar to that o6 codeine or de8tro%ro%o8y%hene and th!& ha& %otential 6or a1!&e7 Fithdra/al &y*%to*& *ay occ!r i6 dr!" i& &to%%ed a1r!%tly7 Red!ce do&a"e "rad!ally7

DRUG GENERIC NAME: Ce6tria8one BRAND NAME: Roce%hin THERAPEUTIC CLASS: Anti in6ecti5e& PHARMAC#L#GIC CLASS: Third "eneration ce%halo&%orin& D#CT#R'S #RDER: Ce6tria8one 2" I+ , 2$ . ANST @ A DATE STARTED: 0e1r!ary 2?3 $)2) DATE DISC#NTINUE:

ACTION Third "eneration ce%halo&%orin that onh1it cell /all &ynthe&i&3 %ro*oin" o&*otic in&ta1ility= !&!ally 1actericidal7

INDICATIONS Unco*%licatad "onococcal 5a"initi& UTI= lo/er re&%iratory tract3 1one o%r 9oint3 intra a1do*inal3 &;in or &;in &tr!ct!re= &e%tice*ia7 Menin"iti& Peri o%erati5e %re5ention Ac!te 1acterial otiti& *edia Ne!rolo"ic co*%lication&3 carditi&3and arthriti& 6ro* %enicillin7

CONTAINDICATION S Contraindicated in %atient& hy%er&en&iti5e to dr!" or other ce%halo&%horin&7 U&e ca!tio!&ly in %atient& hy%er&en&iti5e to %enicillin 1eca!&e o6 %o&&i1ility o6 cro&& &en&iti5ity /ith other 1eta lacta* anti1iotic&7 U&e ca!tio!&ly in 1rea&t 6eedin" /o*en and in %atient& /ith hi&tory o6 coliti& and renal in&!66iciency7

SIDE / ADVERSE REACTIONS CNS: 6e5er3 headache3 di>>ine&& C+: %hle1iti& GI: %&e!do*e*1rano!& coliti&3 diarrhea GU: "enital %r!rit!&3 candidia&i&3 HEMAT#L#GIC:eo&i no%hilia3 thro*1ocyto&i&3 le!co%enia7 SCIN: %ain3 in d!ration3 tenderne&& at in9ection &ite3 ra&h3 %r!rit!&7 #THER: hy%er&en&iti5ity reaction&3 &er!*&ic;ne&&3ana%hyl a8i&3 chill&7

NURSING CONSIDERATION Be6ore "i5in" dr!"3 a&; %atient i6 he i& aller"ic to %enicillin& or other ce%halo&%orin& #1tain &%eci*en 6or c!lt!re and &en&iti5ity te&t& 1e6ore "i5in" 6ir&t do&e7 Thera%y *ay 1e"in /hile a/aitin" re&!lt&7 An I7M7 ;it containin" 2G lidocaine a& a dil!ent i& a5aila1le 6ro* the *an!6act!rer7 0or I7M7 !&e in9ect dee% into a lar"e *!&cle3 &!ch a& the "l!te!& *a8i*!& and the lateral a&%ect o6 the thi"h7 I6 lar"e do&e& are "i5en3 thera%y i& %rolon"ed73 or %atient i& at hi"h ri&;3 *onitor %atient 6or &i"n and &y*%to*& o6

&!%er in6ection7 Dr!" i& co**only !&ed in ho*e anti1iotic %ro"ra*& 6or o!t%atient treat*ent o6 &erio!& in6ection&7

DRUG GENERIC NAME: Aceta*ino%he n4 %araceta*ol BRAND NAME: A%enol3Bane&i n3 Dy*adon THERAPEUTIC CLASS: Non o%iod anal"e&ic and anti%yretic&7 PHARMAC#L#GIC CLASS: Para a*ino%henol deri5ati5e D#CT#R'S #RDER: Paraceta*ol 2 a*% , HI PRN DATE STARTED: )$ 2)3 $)2) DATE DISC#NTINUE:

ACTION Tho!"ht to %rod!ce anal"e&ia 1y 1loc;in" %ain i*%!l&e& 1y inhi1itin" &ynthe&i& o6 %ro&ta"landin in the CNS or o6 other &!1&tance& that &en&iti>e %ain rece%tor& to &ti*!lation7 The dr!" *ay relie5e 6e5er thro!"h central action in hy%othala*ic heat re"!latin" center7

INDICATIONS Mild %ain or 6e5er7

CONTRAINDICATIO NS Contraindicated in %atient& hy%er&en&iti5e to dr!"7 U&e ca!tio!&ly in %atient& /ith lon" ter* alcohol !&e 1eca!&e thera%e!tic do&e& ca!&e he%atoto8icity in %atient&7

SIDE / ADVERSE REACTIONS HEMAT#L#GIC: he*olytic ane*ia3 le!co%enia3 ne!tro%enia3 %ancyto%enia7 HEPATIC: 9a!ndice METAB#LIC: hy%o"lyce*ia S;in: ra&h3 !rticaria7

NURSING CONSIDERATION Alert: Many #TC and %re&cri%tion %rod!ct& contain aceta*ino%hen= 1e a/are o6 thi& /hen calc!latin" daily do&e7 U&e li,!id 6or* 6or children and %atient& /ho ha5e di66ic!lty &/allo/in"7 In children3 don't e8ceed 6i5e do&e& in $H ho!r&7

Sa*1on" @Bl!*ea Bal&a*i6eraA Doctor'& #rder: Sa*1on" ())*" $ ca% TID Date Started: 0e1r!ary 223 $)2)
A %lant that reache& 2 J to E *eter& in ht /ith ro!"h hairy lea5e&7 Do!n" %lant& aro!nd *other %lant *ay 1e &e%arated /hen they ha5e E or *ore lea5e&7 USES: Anti ede*a3 di!retic3 anti !rolithia&i&7 Boil cho%%ed lea5e& in a "la&& o6 /ater in 2( *in7 !ntil one "la&& re*ain&7 Cool and &train

NAME OF DRUG

ACTION

INDICATION

CONTRAINDICATIO NS

SIDE EFFECTS / ADVERSE REACTIONS Sli"ht "a&trointe&tinal di&order& *ay a%%ear /hich can 1e %alliated 1y *ean& o6 the 9oint ad*ini&tration o6 6ood7

NURSING CONSIDERATIONS

Generic Na*e: Pota&&i!* Citrate

The ai* o6 the treat*ent i& to re&tore the le5el o6 the !rinary citrate and to increa&e the %H o6 !rine to K ?7

Brand Na*e: Acal;a

Cla&&i6ication: CLINICAL: Anti!rolithic D#CT#R'S #RDER: Acal;a 2)*" 2 ta1 TID DATE STARTED: 0e1r!ary 223 $)2) DATE DISC#NTINUE:

Treat*ent o6 %atient& /ith renal lithia&i& and hy%ocitrat!ria3 chronic 6or*er& o6 calci!* o8alate3 %ho&%ate calc!lia7 Uric acid lithia&i& alone or acco*%anied 1y calci!* lithia&i&7 Renal t!1!lar acido&i& /4 Ca ne%hrolithia&i&7

renal in&!66iciency3 %er&i&tent al;aline !rinary in6ection&3 o1&tr!ction o6 the !rinary tract3 hy%er;ale*ia3 re&%iratory or *eta1olic al;alo&i&3 acti5e %e%tic !lcer3 inte&tinal o1&tr!ction3 %atient& &!1*itted to anticholiner"ic thera%y3 %atient& /ith &lo/ "a&tric e*%tyin"3 adrenal in&!66iciency7

The ta1let& *!&t not 1e *a&ticated or dil!ted7 The acti5e co*%onent o6 Acal;a i& contained /ith a %oro!& /a8 *atri87 A& thi& /a& *atri8 i& in&ol!1le3 it can 1e eli*inated in 5i&i1le 6or* in the 6ece&7 The acti5e co*%onent3 ho/e5er3 ha& 1een relea&ed in the "a&trointe&tinal tract7 M!&t not 1e ad*ini&tered to %atient& recei5in" %ota&&i!* &%arin" di!retic& @trai*terene3 &%irolactone3 or a*ylorideA7 It i& ad5i&a1le to carry o!t an e5al!ation o6 electrolyte& @Na C ClA and C#$3 creatinine and he*o"ra* e5ery H hr&7 It i& reco**ended that the %atient& in treat*ent /ith Acal;a 6ollo/ a diet /4o &alt and increa&e the inta;e o6 6l!id&7

The reco**ended treat*ent in ca&e o6 hy%er%ota&&e*ia i&: I+ ad*ini&tratioin 6 2)G de8tro&e &ol!tion3 containin" 2) 2$ !nit& o6 in&!lin42)))*l7 Correction o6 the %o&&i1le acido&i& /ith I+ &odi!* 1icar1oate and he*odialy&i& or %eritoneal dialy&i&7

DRUG GENERIC NAME: 0!ro&e*ide BRAND NAME: La&i8 PHARMAC#L#GI C CLASS: Loo% Di!retic D#CT#R'S #RDER: 0!ro&e*ide H) *" no/ DATE STARTED: 0e1r!ary -3 $)2) DATE DISC#NTINUE:

ACTION inhi1it& &odi!* and chloride rea1&or%tion at the %ro8i*al and di&tal t!1!le& and the a&cendin" loo% o6 Henle

INDICATIONS ac!te %!l*onary ede*a ede*a hy%erten&ion

CONTRAINDICATIO NS An!ria he%atic co*a L %reco*a &e5ere hy%o;ale*ia L4or hy%onatre*ia hy%o5ole*ia /4 or /4o hy%oten&ion Hy%er&en&iti5ity to 6!ro&e*ide or &!l6ona*ide&

SIDE / ADVERSE REACTIONS 5erti"o3 di>>ine&&3 headache3 %are&the&ia3 ortho&tatic hy%oten&ion3 thro*1o%hle1iti&3 a1do*inal %ain3 hy%o;ale*ia3 ane*ia *!&cle &%a&*

NURSING CONSIDERATION To %re5ent noct!ria3 "i5e %re%aration in the *ornin" and early in the a6ternoon Fatch 6or &i"n& o6 h%o;ale*ia do not con6!&e /ith Tor&e*ide or La&i8 /ith Lono8 ad5i&e %atient to ta;e dr!" /ith 6ood to %re5ent GI !%&et in6or* %atient o6 %o&&i1le need 6or %ota&&i!* or *a"ne&i!* &!%%le*ent&

DRUG GENERIC NAME: Nat!ral Ter%ene BRAND NAME: Ro/atine8 CLASSI0ICATI# N Anti!rolithi c D#CT#R'S #RDER: Ro/atine8 2ca% TID DATE STARTED: 0e1r!ary 223 $)2) DATE DISC#NTINUE:

ACTION Pro*ote& a di!re&i& and rela8e& !rinary tract &%a&*3 th!& a&&i&tin" the %a&&a"e o6 &tone&7 The thera%e!tic e66ect& o6 the 1alanced co*1ination o6 ter%ene& red!ce& !rinary tract in6la**ation3 &ti*!latin" renal 1lood 6lo/ thro!"h the ;idney& and increa&in" the o!t%!t o6 le&& concentrated !rine7

INDICATIONS Li,!id inta;e &ho!ld 1e increa&ed d!rin" thera%y Store at te*%7 not e8ceedin" E)oc7Ne%hrolithi a&i&3 Urolithia&i&3Cy& ti&i&3 Renal Colic3 UTI3 Po&t o% %ro%hyla8i& o6 calc!li3 treat*ent o6 !rinary tract &%a&* and in6la**ation7

CONTRAINDICATIO NS Contraindicated in %atient& hy%er&en&iti5e to dr!"

SIDE / ADVERSE REACTIONS CNS: di>>ine&&3 headache GI: Na!&ea3 con&ti%ation7

NURSING CONSIDERATION Li,!id inta;e &ho!ld 1e increa&ed d!rin" thera%y Store at te*%7 not e8ceedin" E)oc7

DRUG GENERIC NAME: #r%henadin e THERAPEUTIC CLASS: S;eletal *!&cle rela8ant& PHARMAC#L#GI C CLASS: Di%henhydr a*ine D#CT#R'S #RDER: #r%henadin eM Paraceta*ol 2ta1 TID DATE STARTED: 0e1r!ary 2$3 $)2) DATE DISC#NTINUE:

ACTION S;eletal *!&cle rela8ation3 %ro1a1ly d!e to CNS de%re&&ion7 Thera%e!tic e66ect&: S;eletal *!&cle rela8ation3 /ith decrea&ed di&co*6ort7

INDICATIONS Ad9!nct to re&t and %hy&ical thera%hy in the treat*ent o6 *!&cle &%a&*7

CONTRAINDICATIO NS Hy%er&en&iti5ity3 Bladder nec; o1&tr!ction3 Pro&tatic hy%er%la&ia3 Gla!co*a3 Mya&thenia Gra5i&3 Pe%tic !lcer di&ea&e3 GI o1&tr!ction7

SIDE / ADVERSE REACTIONS CNS: CNS E8citation3 con6!&ion3 di>>ine&&3dro/&ine&&3 EENT: 1l!rred 5i&ion3 dry eye& GI: con&ti%ation3 dry *o!th GU: Urinary retention

NURSING CONSIDERATION Ad5ice %atient to ta;e *edication a& directed7 Ta;e *i&&ed do&e& /ithin one ho!r=i6 noy3ret!rn to re"!lar do&in" &ched!le7Do not do!1le do&e&7 Enco!ra"e %atient to co*%ly /ith additional thera%ie& %re&cri1ed 6or *!&cle &%a&*@re&t3%hy&ical thera%y3heatA May ca!&e di>>ine&&3dro/&ine&&31l! rred 5i&ion7Ad5ice %atient to a5oid dri5in" and other acti5itie& re,!irin" alertne&& !ntil re&%on&e to dr!" i& ;no/n In&tr!ct %atient to *a;e %o&ition chan"e& &lo/ly to *ini*i>e ortho&tatic retention7 Ad5ice %atient to a5oid conc!rrent !&e o6 alcohol and other CNS de%re&&ant& /hile ta;in" thi& *edication

DRUG GENERIC NAME: 0erro!& S!l6ate THERAPEUTIC CLASS: Anti ane*ic& PHARMAC#L#GI C CLASS: Iron &!%%le*ent D#CT#R'S #RDER: 0erro!& S!l6ate 2ca% #D DATE STARTED: 0e1r!ary 2$3 $)2) DATE DISC#NTINUE:

ACTION An e&&ential *ineral 6o!nd in he*o"lo1in3 *yo"lo1in3 and *any en>y*e&7 Enter& the 1lood &trea* and i& tran&%orted to the or"an& o6 the retic!loendothelial &y&te*@ li5er3 &%leen3 1one *arro/A3 /here it i& &e%arated o!t and 1eco*e& %art o6 iron &tore&7

INDICATIONS Pre5ention or treat*ent o6 iron de6iciency ane*ia in %atient /ith chronic ;idney di&ea&e incl!din" %atient& /ho are not in dialy&i& and %atient& de%endent on dialy&i&

CONTRAINDICATIO NS He*ochro*ato&i&7 He*o&idero&i&3 or other e5idence o6 Iron o5erload= &o*e %rod!ct& contain alcohol3 Tartra>ine3or &!l6ite& &ho!ld 1e a5oided in %atient& /ith ;no/n intolerant& or hy%er&en&iti5ity

SIDE / ADVERSE REACTIONS CNS:di>>ine&&3 headache GI: na!&ea3 dar; &tool&3 "a&tric %ain C+:hy%oten&ion

NURSING CONSIDERATION E8%lain %!r%o&e o6 iron thera%y to %atient7 Enco!ra"e %atient to co*%ly /ith *edication re"i*en Ad5ice %atient that &tool& *ay 1eco*e dar; "reen or 1lac; and that thi& chan"e *ay 1e har*le&&7 In&tr!ct %atient to 6ollo/ a diet hi"h in Iron7

DRUG GENERIC NAME: Si*5a&tatin THERAPEUTIC CLASS: Li%id lo/erin" a"ent& PHARMAC#L#GI C CLASS: HMG CoA Red!cta&e Inhi1itor& D#CT#R'S #RDER: Si*5a&tatin $)*" 2ta1 #D DATE STARTED: 0e1r!ary $(3 $)2) DATE DISC#NTINUE

ACTION Inhi1it& an en>y*e3 E hydro8y E *ethyl"l!tarine coEn>y*e red!cta&e3 /hich i& re&%on&i1le6or cataly>in" an early &te% in the &ynthe&i& o6 chole&terol7

CONTRAINDICATIO NS Ad9!ncti5e Hy%er&en&iti5ity= *ana"e*ent o6 Acti5e Li5er di&ea&e %ri*ary or !ne8%lained hy%erchole&terole* %er&i&tent increa&e in ia and *i8ed AST or ALT=#B3 dy&li%ide*ia& Lactation: Pre"nancy or Secondary lactation @%otential %re5ention o6 6or 6etal ano*alie&A= Cardio5a&c!lar conc!rrent !&e o6 e5ent& in %atient& Ge*6ri1ro>il or /ith clinically A>ole anti6!n"al= CHD or tho&e at conc!rrent !&e o6 hi"h ri&; 6or CHD Nel6ina5ir or Ritona5ir @/ith Lo5a&tatin or Si*5a&tatinA INDICATIONS

SIDE / ADVERSE REACTIONS CNS: di>>ine&&3 headache GI: con&ti%ation3 a1do*inal cra*%& Der*i&: ra&he&

NURSING CONSIDERATION #1tain a dietary hi&tory3 e&%ecially /ith re"ard to 6at con&!*%tion7 LAB te&t con&ideration&: E5al!ate &er!* chole&terol and Tri"lyceride le5el& 1e6ore initiatin"3 a6ter H K /ee;& o6 thera%y3 and %eriodically therea6ter Monitor li5er 6!nction te&t3 incl!din" AST3 1e6ore3 at 2$ /ee;& a6ter initiation o6 thera%y or a6ter do&e ele5ation3 and then e5ery , K *o7 I6 AST le5el increa&e to three ti*e& nor*al3 HMG CoA Red!cta&e Inhi1itor Thera%y &ho!ld 1e red!ce or di&contin!ed7May al&o ca!&e increa&e al;aline %ho&%hata&e and 1ilir!1in le5el7

NAME OF DRUG

ACTION

INDICATION

CONTRAINDICATIO NS

SIDE EFFECTS / ADVERSE REACTIONS Dry *o!th3 1l!rred 5i&ion3 red!ced a1ility to &/eat3 tachycardia3 con&ti%ation3 !rinary retention3 aller"ic &;in reaction&

NURSING CONSIDERATIONS

Generic Na*e: Hyo&ci ne N 1!tyl1 ro*ide

Brand Na*e: A*!ci n B!&co %an

Hyo&cine &to%& the &%a&*& in the &*ooth *!&cle 1y %re5entin" acetylcholine 6ro* actin" on the *!&cle7 It doe& thi& 1y 1loc;in" the rece%tor& on the *!&cle cell& that the acetylcholine /o!ld nor*ally act on7

Cla&&i6ication: CLINICAL: Anti&%a&*odi c D#CT#R'S #RDER: HNBB 2a*% I+ e5ery ho!r&7 DATE STARTED: 0e1r!ary E3 $)2) DATE DISC#NTINUE:

S%a&*& o6 the &to*ach3 inte&tine& or 1ile d!ct @"a&trointe&tina l tractA3 incl!din" tho&e a&&ociated /ith irrita1le 1o/el &yndro*e @IBSA7 S%a&*& o6 the re%rod!cti5e or !rinary &y&te*& @"enito!rinary tractA3 6or e8a*%le %eriod %ain cra*%&7 Mana"e*ent o6 *otion &ic;ne&& L other 6or*& o6 na!&ea L 5o*itin"

Gla!co*a3 %ro&tatic hy%ertro%hy3 tachycardia3 *e"acolon L *echanical &teno&i& in GIT7

Monitor %!l&e and 1lood %re&&!re7 May ca!&e dro/&ine&&3 di>>ine&&3 1l!rred 5i&ion7 A5oid ta&;& re,!irin" alertne&&3 *otor &;ill& !ntil re&%on&e to dr!" i& e&ta1li&hed7 In6or* %hy&ician i6 &e5ere con&ti%ation occ!r7 Dry crac;er&3 cola *ay relie5e na!&ea7 Pal%ate 1ladder 6or !rinary retention7 Si%& o6 te%id /ater *ay relie5e dry *o!th7 Enco!ra"e oral 6l!id& 6or con&ti%ation7

You might also like